| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |